Recombinant human growth differentiation factor-9 improves oocyte reprogramming competence and subsequent development of bovine cloned embryos.
Previously, we found that oocyte-secreted factors (OSFs) secreted by denuded oocytes during in vitro maturation (IVM) enhance subsequent development of bovine somatic cell nuclear transfer (SCNT) embryos. This treatment requires many oocytes during IVM. Hence, the aim of this study was to investigate whether supplementing with recombinant growth differentiation factor-9 (GDF9), one of crucial OFSs, in oocyte maturation medium could improve developmental competence of bovine oocytes and subsequent development of cloned embryos. Cumulus-oocyte complexes (COCs) from antral follicles of bovine ovaries collected from an abattoir were cultured with (SCNT+GDF9 group) or without (SCNT group) 200 ng/mL recombinant human GDF9 in oocyte maturation medium. After 22 h, metaphase II (MII) oocytes were used for SCNT. The presence of 200 ng/mL GDF9 significantly increased oocyte maturation rates, the cleavage rate, and blastocyst formation rates of bovine cloned embryos. The blastocyst total, inner cell mass (ICM) cell numbers, and ratio of ICM:TE were higher, whereas the rate of apoptosis in bovine cloned blastocysts was lower in the SCNT+GDF9 group than in the SCNT group. The histone modifications at various sites were also different between each group. These results suggest that COCs cultured with recombinant GDF9 in oocyte maturation medium improve oocyte developmental competence and subsequent developmental competence of cloned embryo in cattle.
1 College of Veterinary Medicine, Northwest A&F University , Yangling, Shaanxi, 712100, PR China .
Jianmin
J
Su
Guangdong
G
Hu
Yongsheng
Y
Wang
Dong
D
Liang
Mingqing
M
Gao
Hongzheng
H
Sun
Yong
Y
Zhang
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001755:Blastocyst / Q000166:cytology / Q000378:metabolism*; D002417:Cattle; D065150:Cellular Reprogramming / Q000187:drug effects*; D019976:Cloning, Organism; D055429:Growth Differentiation Factor 9 / Q000494:pharmacology*; D006801:Humans; D008677:Metaphase / Q000187:drug effects*; D009865:Oocytes / Q000166:cytology / Q000382:microbiology*; D011994:Recombinant Proteins / Q000494:pharmacology
C525897:GDF9 protein, human; D055429:Growth Differentiation Factor 9; D011994:Recombinant Proteins